PMA device
Onyx Liquid Embolic System (Onyx LES)
Ev3 Neurovascular · Agent, Injectable, Embolic (MFE, Class III) · First FDA decision Jul 21, 2005, newest Oct 14, 2026Brain aneurysmBrain bleeding (hemorrhagic stroke)
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
5
PMA pathway
Device trials
10
Naming "Onyx Liquid"
MAUDE reports
0
Brand "Onyx Liquid", since 2015
PubMed studies
81
Mentioning "Onyx Liquid"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Onyx Liquid Embolic System (Onyx LES)
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 0 of 5 decisions filed under this name.
FDA's records could not be loaded.
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Onyx Liquid", any status and sponsor, newest update first.
- Comparative Study of Embolic Agents in Patients With Subdural Hemorrhage Undergoing Middle Meningeal Artery (MMA) EmbolizationNot yet recruiting
Sanford HealthAcademic, hospital or other
NCT07757113 · 30 participants (planned) · Start Mar 2027 · Primary completion Mar 2028
Device: Particles (polyvinyl alcohol or similar microspheres); Liquid Embolics (Onyx, n-BCA, or equivalent) and 1 more · For: Chronic Subdural Hematoma; Stroke; Middle Meningeal Artery Embolization
Sites: Sioux Falls, South Dakota
- Onyx™ Liquid Embolic IDE Clinical StudyRecruiting
Medtronic EndovascularPublic (MDT)
NCT06742801 · 119 participants (planned) · Start May 9, 2025 · Primary completion Apr 2027
Device: Onyx™ Liquid Embolic System · For: Peripheral Arterial Hemorrhage; Trauma; GI Bleed and 2 more
Sites: Phoenix, Arizona; Irvine, California; Los Angeles, California · 20 sites in all
- MMA Embolization With NeoCast for Subacute and Chronic Subdural HematomaPivotal-lookingRecruiting
Arsenal Medical, Inc.Not on our public-company list
NCT07541404 · 360 participants (planned) · Start Aug 13, 2026 · Primary completion Jan 2028
Device: NeoCast Embolic System; Onyx LES, an FDA-Approved Commercial Liquid Embolic · For: Subdural Hematoma
Sites: New Haven, Connecticut; Seattle, Washington
7 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Onyx Liquid", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code MFE
0 reports: 0 malfunction, 0 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Onyx Liquid"[tiab]. The summary above synthesizes these.
- Management of a fractured microcatheter during middle meningeal artery embolization.
Webb M, Luo A, Al Saiegh F, et al. · J Neurointerv Surg · 2024Case Reports
- Onyx embolization for salvage hemostasis after intraoperative rupture.
Lee RP, Diaz O, Gonzalez LF · J Neurointerv Surg · 2024Case Reports, Video-Audio Media
- Embolization of middle meningeal artery for chronic subdural hematoma: Do we have sufficient evidence?
Shankar J, Alcock S, Milot G · Interv Neuroradiol · 2025Editorial
- Consensus Statement on Middle Meningeal Artery Embolization in Chronic Subdural Hematoma Treatment: A Guideline from the Society of Vascular and Interventional Neurology Guidelines and Practice Standards Committee.
Siddiq F, Shakir M, Nguyen TN, et al. · Stroke Vasc Interv Neurol · 2025Review
- Onyx Liquid Embolic Agent: Basic Knowledge for Its Use in Interventional Neuroradiology.
Kojima T, Maeda T, Ito Y, et al. · J Neuroendovasc Ther · 2025Review
- Percutaneous transorbital embolization of a carotid cavernous fistula.
Lyons LJ, Smith SA, Diaz O, et al. · Proc (Bayl Univ Med Cent) · 2019Case Reports
- Pseudoaneurysm of the Pterygoid Artery After a Gunshot to the Face.
Smerin D, Al Saiegh F · World Neurosurg · 2023Case Reports
- Onyx embolization of anterior condylar confluence dural arteriovenous fistula.
Takemoto K, Tateshima S, Rastogi S, et al. · J Neurointerv Surg · 2014Case Reports
- Onyx Cast Migration to the Right Ventricle Following Trans-arterial Embolization of a Cranial Dural Arteriovenous Fistula.
Habib M, Morton G · Cureus · 2023Case Reports
- Coil embolization of distal vascular lesion using a 1.5 Fr Marathon microcatheter and 'free-running' technique.
Ou CH, Cheng CS, Winardi W, et al. · J Neurointerv Surg · 2025Video-Audio Media
- Bilateral optic disc collaterals secondary to high-flow dural arteriovenous fistula: a diagnostic dilemma.
Kulkarni Irlekar SD, Kekunnaya R, Sachdeva V · BMJ Case Rep · 2024Case Reports
- Indirect carotid cavernous fistula mimicking ocular myasthenia.
Leishangthem L, Satti SR · BMJ Case Rep · 2017Case Reports
Other devices of this type
Also filed under product code MFE.
- Apollo Onyx Delivery Micro CatheterEv3 Neurovascular · PMA 2021
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.